Company
Headquarters: Ãvry, France
Employees: 50
CEO: Dr. Bernard Courtieu DVM, MBA
€5.8 Million
EUR as of Jan. 1, 2024
US$6.5 Million
Company | Market Cap (USD) |
---|---|
Novo Nordisk | $461.52 B |
Vertex Pharmaceuticals Incorporated | $107.23 B |
Regeneron Pharmaceuticals, Inc. | $100.01 B |
CSL Limited | $94.74 B |
Marinomed Biotech AG | $73.23 B |
Company | Market Cap (USD) |
---|---|
Lilly | $586.39 B |
UnitedHealth Group | $504.47 B |
Novo Nordisk | $461.52 B |
Johnson & Johnson | $387.50 B |
Merck | $296.51 B |
IntegraGen SA provides human genome analysis services for academic and private laboratories in France and the United States. Its genomic services include transcriptomics, epigenomics, DNA sequencing, NGS testing for cancer research, and SNP genotyping. The company offers clinical research services, such as clinical grade sequencing and pharmacogenomics; basic and human genetic research; agrigenomic services, including crop and livestock genotyping and high-throughput sequencing for crops and livestock; and microbial genomics services comprising whole-genome microbial sequencing and microbial transcriptomics. It also provides MERCURY, a tool for assisting in the interpretation of exome and transcriptome data in oncology that allows biologists and pathologists to transform the data into a biological report that is used in clinical and translational research; SIRIUS, an online solution to identify genetic variants in rare diseases with mendelian transmission, or somatic variants in oncology; Galileo, a cloud-based app that allows researchers to analyze RNA data; and GeCo, a tool that provides genomic data analysis services. IntegraGen SA was founded in 2000 and is headquartered in àvry, France.
Top 1-year algo backtest: +284.14%
$10,000 in April 2023 would now be $38,414 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
IntegraGen has the following listings and related stock indices.
Stock: Euronext: ALINT wb_incandescent